Bio-Techne Certifies over 1,000 Antibodies for Simple Western

Go back to Bio-Techne Certifies over 1,000 Antibodies for Simple Western

Bio-Techne (TECH) Misses Q1 EPS by 6c

October 28, 2015 7:06 AM EDT

Bio-Techne (NASDAQ: TECH) reported Q1 EPS of $0.79, $0.06 worse than the analyst estimate of $0.85. Revenue for the quarter came in at $12.4 million versus the consensus estimate of $116.4 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.

... More